Gabaergic drugs, morphine and morphine tolerance

A study in relation to nociception and gastrointestinal transit in mice

Subbiah Sivam, I. K. Ho

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Agonists and antagonists of γ-aminobutyric acid, i.e. GABAergic drugs, such as muscimol, badofen or bicuculline, alone or in combination, exhibited analgesic effects per se and enhanced the analgesia induced by morphine. The analgesic effects of GABAergic drugs were unaffected by admini tration of naloxone in a dose which antagonized the analgesia induced by morphine. The ED50 for the antinociceptive effect of muscimol, bicuculline, picrotoxin, gabaculline or aminooxyacetic acid (AOAA) was not affected in the morphine-tolerant group as compared to the control group, in contrast to the increase in the ED50 for morphine under similar conditions; this indicated that there was no development of cross-tolerance between morphine and GABAergic drugs. Muscimol suppressed the abrupt withdrawal-jumping induced by morphine and enhanced the suppression of this phenomenon by morphine. The GABAergic drugs also shared with morphine the property of inhibiting gastrointestinal (GIT) motility. Naloxone reversed the inhibition of motility induced by morphine but failed to influence that induced by GABAergic drugs. In the morphine-tolerant state, the sensitivity of gastrointestinal motility to morphine decreased, whereas, the sensitivity to GABAergic drugs remained unaltered. The results indicate that GABAergic drugs share some of the classical properties of morphine, such as analgesia and inhibition of gastrointestinal motility, but they probably do so by different mechanisms.

Original languageEnglish (US)
Pages (from-to)767-774
Number of pages8
JournalNeuropharmacology
Volume22
Issue number6
DOIs
StatePublished - 1983
Externally publishedYes

Fingerprint

Gastrointestinal Transit
Nociception
Morphine
Pharmaceutical Preparations
Muscimol
Gastrointestinal Motility
Analgesia
Bicuculline
Naloxone
Analgesics
Aminooxyacetic Acid
Aminobutyrates
Picrotoxin

Keywords

  • analgesia
  • GABA
  • GABAergic drugs
  • gastrointestinal transit
  • morphine
  • opiate tolerance

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Gabaergic drugs, morphine and morphine tolerance : A study in relation to nociception and gastrointestinal transit in mice. / Sivam, Subbiah; Ho, I. K.

In: Neuropharmacology, Vol. 22, No. 6, 1983, p. 767-774.

Research output: Contribution to journalArticle

@article{4471904736d7439e82689d6d2931b094,
title = "Gabaergic drugs, morphine and morphine tolerance: A study in relation to nociception and gastrointestinal transit in mice",
abstract = "Agonists and antagonists of γ-aminobutyric acid, i.e. GABAergic drugs, such as muscimol, badofen or bicuculline, alone or in combination, exhibited analgesic effects per se and enhanced the analgesia induced by morphine. The analgesic effects of GABAergic drugs were unaffected by admini tration of naloxone in a dose which antagonized the analgesia induced by morphine. The ED50 for the antinociceptive effect of muscimol, bicuculline, picrotoxin, gabaculline or aminooxyacetic acid (AOAA) was not affected in the morphine-tolerant group as compared to the control group, in contrast to the increase in the ED50 for morphine under similar conditions; this indicated that there was no development of cross-tolerance between morphine and GABAergic drugs. Muscimol suppressed the abrupt withdrawal-jumping induced by morphine and enhanced the suppression of this phenomenon by morphine. The GABAergic drugs also shared with morphine the property of inhibiting gastrointestinal (GIT) motility. Naloxone reversed the inhibition of motility induced by morphine but failed to influence that induced by GABAergic drugs. In the morphine-tolerant state, the sensitivity of gastrointestinal motility to morphine decreased, whereas, the sensitivity to GABAergic drugs remained unaltered. The results indicate that GABAergic drugs share some of the classical properties of morphine, such as analgesia and inhibition of gastrointestinal motility, but they probably do so by different mechanisms.",
keywords = "analgesia, GABA, GABAergic drugs, gastrointestinal transit, morphine, opiate tolerance",
author = "Subbiah Sivam and Ho, {I. K.}",
year = "1983",
doi = "10.1016/0028-3908(83)90101-6",
language = "English (US)",
volume = "22",
pages = "767--774",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Gabaergic drugs, morphine and morphine tolerance

T2 - A study in relation to nociception and gastrointestinal transit in mice

AU - Sivam, Subbiah

AU - Ho, I. K.

PY - 1983

Y1 - 1983

N2 - Agonists and antagonists of γ-aminobutyric acid, i.e. GABAergic drugs, such as muscimol, badofen or bicuculline, alone or in combination, exhibited analgesic effects per se and enhanced the analgesia induced by morphine. The analgesic effects of GABAergic drugs were unaffected by admini tration of naloxone in a dose which antagonized the analgesia induced by morphine. The ED50 for the antinociceptive effect of muscimol, bicuculline, picrotoxin, gabaculline or aminooxyacetic acid (AOAA) was not affected in the morphine-tolerant group as compared to the control group, in contrast to the increase in the ED50 for morphine under similar conditions; this indicated that there was no development of cross-tolerance between morphine and GABAergic drugs. Muscimol suppressed the abrupt withdrawal-jumping induced by morphine and enhanced the suppression of this phenomenon by morphine. The GABAergic drugs also shared with morphine the property of inhibiting gastrointestinal (GIT) motility. Naloxone reversed the inhibition of motility induced by morphine but failed to influence that induced by GABAergic drugs. In the morphine-tolerant state, the sensitivity of gastrointestinal motility to morphine decreased, whereas, the sensitivity to GABAergic drugs remained unaltered. The results indicate that GABAergic drugs share some of the classical properties of morphine, such as analgesia and inhibition of gastrointestinal motility, but they probably do so by different mechanisms.

AB - Agonists and antagonists of γ-aminobutyric acid, i.e. GABAergic drugs, such as muscimol, badofen or bicuculline, alone or in combination, exhibited analgesic effects per se and enhanced the analgesia induced by morphine. The analgesic effects of GABAergic drugs were unaffected by admini tration of naloxone in a dose which antagonized the analgesia induced by morphine. The ED50 for the antinociceptive effect of muscimol, bicuculline, picrotoxin, gabaculline or aminooxyacetic acid (AOAA) was not affected in the morphine-tolerant group as compared to the control group, in contrast to the increase in the ED50 for morphine under similar conditions; this indicated that there was no development of cross-tolerance between morphine and GABAergic drugs. Muscimol suppressed the abrupt withdrawal-jumping induced by morphine and enhanced the suppression of this phenomenon by morphine. The GABAergic drugs also shared with morphine the property of inhibiting gastrointestinal (GIT) motility. Naloxone reversed the inhibition of motility induced by morphine but failed to influence that induced by GABAergic drugs. In the morphine-tolerant state, the sensitivity of gastrointestinal motility to morphine decreased, whereas, the sensitivity to GABAergic drugs remained unaltered. The results indicate that GABAergic drugs share some of the classical properties of morphine, such as analgesia and inhibition of gastrointestinal motility, but they probably do so by different mechanisms.

KW - analgesia

KW - GABA

KW - GABAergic drugs

KW - gastrointestinal transit

KW - morphine

KW - opiate tolerance

UR - http://www.scopus.com/inward/record.url?scp=0020529204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020529204&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(83)90101-6

DO - 10.1016/0028-3908(83)90101-6

M3 - Article

VL - 22

SP - 767

EP - 774

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 6

ER -